AU Patent

AU2020202668A1 — Syringe devices

Assigned to DMK Pharmaceuticals Corp · Expires 2020-05-14 · 6y expired

What this patent protects

A syringe device comprising: a syringe including a therapeutic dose of at least one drug, a needle and a stopper; and an encasement configured to house the syringe, wherein the encasement includes a proximal end, a distal end, and an encasement window configured to allow a use…

USPTO Abstract

A syringe device comprising: a syringe including a therapeutic dose of at least one drug, a needle and a stopper; and an encasement configured to house the syringe, wherein the encasement includes a proximal end, a distal end, and an encasement window configured to allow a user to view the therapeutic dose of the at least one drug, wherein the encasement includes a needle guard that includes at least one window that aligns with the encasement window when the needle guard is not deployed and wherein the needle guard is manually deployed by moving the needle guard away from the proximal end of the encasement to cover the needle. I IOIAl A- ne n CAOAOnaaO- ~ OllKADOf"I" 1/10 100 250 108 1122 116 10 126 FIG. 1 114 106 1202

Drugs covered by this patent

Patent Metadata

Patent number
AU2020202668A1
Jurisdiction
AU
Classification
—
Expires
2020-05-14
Drug substance claim
No
Drug product claim
No
Assignee
DMK Pharmaceuticals Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.